
1. malar j. 2018 aug 31;17(1):320. doi: 10.1186/s12936-018-2470-7.

deletions pfhrp2 pfhrp3 genes plasmodium falciparum honduras,
guatemala nicaragua.

fontecha g(1), mejía re(2), banegas e(3), ade mp(4), mendoza l(5), ortiz b(5),
sabillón i(5), alvarado g(5), matamoros g(5), pinto a(5).

author information: 
(1)microbiology research institute, universidad nacional autonoma de honduras,
tegucigalpa, honduras. gustavo.fontecha@unah.edu.hn.
(2)panamerican health organization, tegucigalpa, honduras.
(3)national department surveillance, ministry health, tegucigalpa,
honduras.
(4)panamerican health organization, washington, usa.
(5)microbiology research institute, universidad nacional autonoma de honduras,
tegucigalpa, honduras.

background: malaria remains public health problem countries central 
america. rapid diagnostic tests (rdts) one useful tools assist
in diagnosis malaria remote areas. since introduction, wide
variety rdts developed detection different parasite
antigens. pfhrp2 targeted antigen detection plasmodium
falciparum infections. genetic mutations gene deletions important factors
influencing affecting performance rapid diagnostic tests.
methods: order demonstrate presence absence pfhrp2 pfhrp3
genes flanking regions, total 128 blood samples patients with
p. falciparum infection three central american countries analysed
through nested semi-nested pcr approaches.
results: total, 25.8 91.4% isolates lacked region located
between exon 1 exon 2 pfhrp2 pfhrp3 genes, respectively. parasites
from three countries showed deletions one genes. highest
proportion pfhrp2 deletions found nicaragua isolates from
guatemala revealed lowest number pfhrp2 deletions. parasites collected
from honduras showed highest proportion phfrp3 absence (96.2%). twenty-one
percent isolates double negative mutants exon 1-2 segment both
genes, 6.3% isolates lacked full-length coding region genes.
conclusions: study provides molecular evidence existence p.
falciparum isolates lacking pfhrp2 pfhrp3 genes, flanking
regions, honduras, guatemala nicaragua. finding could hinder progress
in control elimination malaria central america. continuous
evaluation rdts molecular surveillance would recommended.

doi: 10.1186/s12936-018-2470-7 
pmcid: pmc6119307
pmid: 30170596  [indexed medline]

